Author Archives for Samantha Floyd

Capricor Collaborates with Lonza for the Development of CAP-1002, its Cell Therapy Candidate for the Treatment of Duchenne Muscular Dystrophy and Other Indications

January 12, 2021 10:14 am Published by Leave your thoughts

Capricor Therapeutics, a clinical-stage biotechnology company focused on the development of the first-in-class cell and exosome-based therapeutics for the treatment and prevention of serious diseases, and Lonza today announced that the companies have entered into an agreement for the development of CAP-1002, Capricor's leading clinical asset using allogeneic cardiosphere-derived cells (CDC) technology for the treatment of Duchenne Muscular Dystrophy (DMD) and complications arising from COVID-19.


Monument Chemical Brandenburg Awarded SOCMA’s 2020 Educational Outreach Award

December 18, 2020 3:22 pm Published by Leave your thoughts

In a year when young people are shifting to online learning more than ever before, the team at Monument Chemical, LLC, Brandenburg, KY, answered the call through its support of the local 4-H "Get STEAM'd Up" initiative, an at-home STEAM (Science, Technology, Engineering, Art, and Math) program. As a result of this exceptional effort to educate a new generation about the importance of specialty chemistry, the Society of Chemical Manufacturers & Affiliates (SOCMA) is awarding Monument Chemical Brandenburg with its 2020 Educational Outreach Award.